Skip to Content

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in News for Health Professionals

Video Games Appear Not to Harm Boys' Social Development

Playing video games is generally not harmful to boys' social development, though it may be associated with less social competence in girls, according to a study published online April 23 in Child Development. Beate W. Hygen, Ph.D., from the Norwegian University of Science and Technology in Trondheim, and colleagues investigated whether the quantity...

Posted today in Medical

'Two Wave' Flu Season Unusually Long: CDC

What looked like a mild flu season in December has turned into the longest flu season in five years, U.S. health officials report. The season is so prolonged because two waves of flu viruses hit one after the other, making it like two flu seasons in one. "Those two waves together have made it a long season and a moderately severe season," said Lynnette...

Posted today in Medical

Americans Sitting More Than Ever, and Tech Is to Blame

America's couch potatoes are becoming ever more deeply rooted, and computers are the reason why. The amount of time people spend sitting around has increased in recent years, driven largely by more leisure time spent with a computer, federal survey data shows. Total daily sitting time increased about an hour a day for teenagers and adults between...

Posted yesterday in New Drug Approvals

FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.3 In clinical trials, Skyrizi produced high rates of durable skin clearance –...

Posted yesterday in News for Health Professionals

Rates of Marijuana Use in Cancer Patients on the Rise in U.S.

Many people with cancer use marijuana, and the rates of use in the United States have increased over time, according to a study published online April 22 in Cancer. After analyzing data from the U.S. National Health and Nutrition Examination Survey between 2005 and 2014, Kathryn R. Tringale, M.D., from the University of California San Diego in La Jolla,...

Posted today in Medical

AHA News: With Humor -- and Brain-Shaped Jell-O -- This Doctor Teaches Kids About Health

One of the most valuable lessons in pediatrician April Inniss' medical career came from an 8-year-old boy. Inniss was just out of medical school and was asked to draw blood from the terrified young patient at a Boston hospital. The child was diagnosed with chronic stomach issues, and had a distrust of health care providers. "He had a reputation for...

Posted today in Medical

Can Pregnancy Put a Damper on Your Career?

Many American women feel less welcome at work once they become pregnant, a new study finds. On the other hand, expectant and new fathers often get a career boost. "We found that pregnant women experienced decreased career encouragement in the workplace only after they disclosed they were pregnant," said study author Samantha Paustian-Underdahl. She's...

Posted today in Medical

Untrained Caregivers Bear Burden of Care for Families: Report

Twenty million largely self-taught home caregivers in the United States perform complex medical tasks for family members and friends, a new report says. That means that half of the nation's 40 million family caregivers do things typically performed by health care professionals, such as giving injections, preparing special diets, handling tube feedings,...

Posted today in Medical

Asthma Myths That Can Hurt You

Even though asthma is common in the United States, there are many misconceptions about the respiratory disease, an allergy/immunology expert says. "Asthma is a serious condition that affects more than 26 million Americans -- more than 8% of the population," Dr. Todd Mahr, president of the American College of Allergy, Asthma and Immunology, said in a...

Posted today in Medical

Can Obesity Shrink Your Brain?

Obese people may show some shrinkage in their brain tissue as early as middle age, a large new study confirms. The study, based on brain scans of thousands of adults in the United Kingdom, found that those with higher body fat levels tended to show differences in brain structure compared to thinner people. Those differences included a lower volume...

Read more news...

Recently added consumer and prescribing information: Evenity, Dovato, Duaklir Pressair, Mavenclad, Mayzent, Sunosi, Zulresso, Spravato, Jeuveau, Ultomiris

Posted in Blog

Worshipping The Wine (or Beer) God or Godess

For many Americans, alcohol is a big part of their life. No matter the occasion, from weddings to birthday parties, family gatherings to date nights, most assume alcohol will be available. In fact, more than 50% of people say they would enjoy a major event less if alcohol was prohibited. But at what point does […]

Posted in Blog

The Veneral Pest Returns

The history of syphilis makes interesting reading. For a start, there’s controversy about its origins. Some believe it to have been prevalent from at least 3000BC, whereas the more popular theory links its general introduction to the world to the return of the Columbus navigators from the New World in 1493. Regardless of its actual […]

Posted in Blog

The Feverish Pricing of MS Treatments

Towards the end of March, the FDA approved two new treatments for multiple sclerosis (MS): Mayzent (siponimod) and Mavenclad (cladribine). Both represent important breakthroughs for people with certain types of MS. But they come at a cost. The wholesale acquisition cost of Mayzent is $88,500 per year. Mavenclad is $99,500 annually. Even for those with […]

See more blog posts or follow us on twitter.